Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Verge Capital Management Pte Ltd is a venture capital firm established in Singapore, focusing on the healthtech sector. Founded to invest in transformative technologies, the firm aims to enhance the accessibility, quality, and efficiency of healthcare. The organization has built a reputation for targeting early-stage companies that are poised to make significant impacts in the healthcare landscape.
Currently, Verge Capital Management manages a portfolio of six companies, reflecting its commitment to investing in innovative healthtech solutions. The firm operates primarily in the United States, Australia, Spain, the United Kingdom, and Singapore, leveraging its geographic diversity to identify promising investment opportunities. As of now, the firm has not publicly disclosed its assets under management (AUM) or specific fund sizes.
Verge Capital Management invests in healthtech companies that represent the future of healthcare. The firm’s investment strategy emphasizes transformative technology within the healthcare system, particularly those that enhance patient engagement and operational efficiency. Verge targets companies in early revenue and pre-regulatory stages, which allows them to support startups that are on the cusp of significant growth.
The firm’s geographic focus includes the United States, Australia, Spain, the United Kingdom, and Singapore, providing a broad canvas for identifying innovative healthtech solutions. Verge Capital Management is particularly interested in companies that leverage artificial intelligence to improve healthcare delivery and patient outcomes.
Verge Capital Management's portfolio includes six notable companies, each contributing to the advancement of healthtech:
These companies exemplify Verge's commitment to investing in transformative technologies that enhance healthcare delivery and patient engagement.
To pitch Verge Capital Management, founders should visit their website at vergecm.com. It is recommended to include a comprehensive pitch deck that outlines the technology, market opportunity, and team background. Response times may vary, so founders should be prepared for a potential wait.
What investment criteria does Verge Capital Management use?
Verge Capital Management focuses on healthtech companies that are in early revenue and pre-regulatory stages. They look for transformative technologies that can enhance the accessibility, quality, and efficiency of healthcare.
How can I pitch to Verge Capital Management?
Founders can submit their pitches through the firm's website at vergecm.com. It is advisable to include detailed information about the technology, market potential, and team in the pitch deck.
What makes Verge Capital Management different from other investors?
Verge Capital Management specializes exclusively in healthtech, focusing on transformative technologies that leverage AI to improve healthcare delivery. Their geographic focus spans multiple regions, allowing them to tap into diverse markets.
What is the geographic scope of Verge Capital Management's investments?
The firm primarily invests in the United States, Australia, Spain, the United Kingdom, and Singapore, targeting innovative healthtech solutions in these regions.
What is the typical check size for investments?
While specific check sizes are not disclosed, Verge Capital Management invests at the pre-seed, seed, and seed-plus stages, which typically involve smaller initial investments aimed at early-stage companies.
What kind of post-investment involvement does Verge Capital Management have?
Verge Capital Management actively supports its portfolio companies through mentorship and operational guidance, helping them navigate the challenges of scaling in the healthtech sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.